Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia

NCT00357682 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00357682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00357682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Completed
Start date
March 10, 2005
Completion date
May 31, 2017
Enrollment
2,557 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, precancerous condition